Risk scores versus natriuretic peptides for identifying prevalent stage B heart failure.

MLA

Gupta, Sachin, et al. “Risk Scores versus Natriuretic Peptides for Identifying Prevalent Stage B Heart Failure.” American Heart Journal, vol. 161, no. 5, May 2011, p. 923–930.e2. EBSCOhost, https://doi.org/10.1016/j.ahj.2011.01.007.

APA

Gupta, S., Rohatgi, A., Ayers, C. R., Patel, P. C., Matulevicius, S. A., Peshock, R. M., Markham, D. W., de Lemos, J. A., Berry, J. D., & Drazner, M. H. (2011). Risk scores versus natriuretic peptides for identifying prevalent stage B heart failure. American Heart Journal, 161(5), 923–930.e2. https://doi.org/10.1016/j.ahj.2011.01.007

Chicago

Gupta, Sachin, Anand Rohatgi, Colby R. Ayers, Parag C. Patel, Susan A. Matulevicius, Ronald M. Peshock, David W. Markham, James A. de Lemos, Jarett D. Berry, and Mark H. Drazner. 2011. “Risk Scores versus Natriuretic Peptides for Identifying Prevalent Stage B Heart Failure.” American Heart Journal 161 (5): 923–930.e2. doi:10.1016/j.ahj.2011.01.007.